Laura Ciaffi

1.2k total citations
35 papers, 547 citations indexed

About

Laura Ciaffi is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Laura Ciaffi has authored 35 papers receiving a total of 547 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Infectious Diseases, 13 papers in Virology and 9 papers in Epidemiology. Recurrent topics in Laura Ciaffi's work include HIV/AIDS Research and Interventions (17 papers), HIV/AIDS drug development and treatment (17 papers) and HIV Research and Treatment (13 papers). Laura Ciaffi is often cited by papers focused on HIV/AIDS Research and Interventions (17 papers), HIV/AIDS drug development and treatment (17 papers) and HIV Research and Treatment (13 papers). Laura Ciaffi collaborates with scholars based in Cameroon, France and Switzerland. Laura Ciaffi's co-authors include Alexandra Calmy, Éric Delaporte, Sinata Koulla‐Shiro, Eitel Mpoudi‐Ngolé, Christian Laurent, Charles Kouanfack, Anke Bourgeois, Rose Mougnutou, Françoise Portaels and Josephine Mbuagbaw and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Laura Ciaffi

34 papers receiving 532 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Laura Ciaffi Cameroon	15	382	236	172	71	62	35	547
Gambo Aliyu Nigeria	12	297 0.8×	242 1.0×	89 0.5×	13 0.2×	33 0.5×	32	424
Tavitiya Sudjaritruk Thailand	11	246 0.6×	150 0.6×	108 0.6×	154 2.2×	33 0.5×	62	442
Nilesh Bhatt Mozambique	16	311 0.8×	232 1.0×	94 0.5×	26 0.4×	5 0.1×	52	556
George A. Yendewa United States	12	223 0.6×	167 0.7×	52 0.3×	52 0.7×	6 0.1×	54	372
Ulrik Bak Dragsted Denmark	11	312 0.8×	145 0.6×	182 1.1×	86 1.2×	15 0.2×	18	406
Ann M. Labriola United States	10	523 1.4×	256 1.1×	294 1.7×	133 1.9×	8 0.1×	14	757
Achara Chaovavanich Thailand	12	535 1.4×	379 1.6×	150 0.9×	37 0.5×	2 0.0×	21	703
D. Méchali France	8	374 1.0×	202 0.9×	177 1.0×	85 1.2×	13 0.2×	24	491
Octavio Mesner United States	10	92 0.2×	145 0.6×	39 0.2×	46 0.6×	55 0.9×	17	316
Elizabeth Petzold United States	11	382 1.0×	130 0.6×	216 1.3×	82 1.2×	3 0.0×	19	557

Countries citing papers authored by Laura Ciaffi

Since Specialization

Citations

This map shows the geographic impact of Laura Ciaffi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Ciaffi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Ciaffi more than expected).

Fields of papers citing papers by Laura Ciaffi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Ciaffi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Ciaffi. The network helps show where Laura Ciaffi may publish in the future.

Co-authorship network of co-authors of Laura Ciaffi

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Ciaffi. A scholar is included among the top collaborators of Laura Ciaffi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Ciaffi. Laura Ciaffi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ciaffi, Laura, et al.. (2025). Cross-sectional assessment of feasibility and acceptability in screening for female genital schistosomiasis (FGS) in two clinical settings in East Province, Cameroon. Parasitology. 152(14). 1490–1496. 1 indexed citations

Fokam, Joseph, Nicolas Ray, Désiré Takou, et al.. (2021). SARS-CoV-2 antibody seroprevalence and associated risk factors in an urban district in Cameroon. Nature Communications. 12(1). 5851–5851. 28 indexed citations

Kaboré, Nongodo Firmin, Amandine Cournil, Armel Poda, et al.. (2021). APOL1 Renal Risk Variants and Kidney Function in HIV-1–Infected People From Sub-Saharan Africa. Kidney International Reports. 7(3). 483–493. 6 indexed citations

Delaugerre, Constance, Sabrina Eymard‐Duvernay, Alix Armero, et al.. (2021). Deep sequencing analysis of M184V/I mutation at the switch and at the time of virological failure of boosted protease inhibitor plus lamivudine or boosted protease inhibitor maintenance strategy (substudy of the ANRS-MOBIDIP trial). Journal of Antimicrobial Chemotherapy. 76(5). 1286–1293. 3 indexed citations

Essomba, Marie-Josiane Ntsama, et al.. (2020). Palliative and end-of-life care of COVID-19 management in sub-Saharan Africa: a matter of concern. Pan African Medical Journal. 35. 2 indexed citations

Essomba, Marie-Josiane Ntsama, et al.. (2020). Palliative and end-of-life care in COVID-19 management in sub-Saharan Africa: a matter of concern.. PubMed. 35(Suppl 2). 130–130. 4 indexed citations

Kaboré, Nongodo Firmin, Armel Poda, Jacques Zoungrana, et al.. (2019). Chronic kidney disease and HIV in the era of antiretroviral treatment: findings from a 10-year cohort study in a west African setting. BMC Nephrology. 20(1). 155–155. 28 indexed citations

Galy, Adrien, et al.. (2018). Implementation and evaluation of a therapeutic patient education programme during a clinical trial in Yaoundé, Cameroon – Trial ANRS-12286/MOBIDIP. Patient Education and Counseling. 101(7). 1262–1269. 1 indexed citations

Villabona‐Arenas, Christian Julián, Sabrina Eymard‐Duvernay, Avelin F. Aghokeng, et al.. (2018). Short Communication: Nucleoside Reverse Transcriptase Inhibitors with Reduced Predicted Activity Do Not Impair Second-Line Therapy with Lopinavir/Ritonavir or Darunavir/Ritonavir. AIDS Research and Human Retroviruses. 34(6). 477–480. 4 indexed citations

10.

Kaboré, Nongodo Firmin, Sabrina Eymard‐Duvernay, Jacques Zoungrana, et al.. (2017). TDF and quantitative ultrasound bone quality in African patients on second line ART, ANRS 12169 2LADY sub-study. PLoS ONE. 12(11). e0186686–e0186686. 1 indexed citations

11.

Ciaffi, Laura, Sabrina Eymard‐Duvernay, Suzanne Izard, et al.. (2017). Efficacy of dual therapy with protease inhibitors plus lamivudine as maintenance treatment in HIV-positive patients on second line in Africa : the ANRS 12286/MOBIDIP trial 96-week results. Journal of the International AIDS Society. 20. 29–29. 1 indexed citations

12.

Guichet, Emilande, Avelin F. Aghokeng, Laetitia Serrano, et al.. (2016). Short Communication: High Viral Load and Multidrug Resistance Due to Late Switch to Second-Line Regimens Could Be a Major Obstacle to Reach the 90-90-90 UNAIDS Objectives in Sub-Saharan Africa. AIDS Research and Human Retroviruses. 32(12). 1159–1162. 25 indexed citations

13.

Ciaffi, Laura, Sinata Koulla‐Shiro, Ndèye Fatou Ngom Gueye, et al.. (2016). Dual therapy with a boosted protease inhibitor plus lamivudine is an effective maintenance strategy in patients on second-line antiretroviral therapy in Africa : the ANRS 12286/MOBIDIP trial. Journal of the International AIDS Society. 19. 2 indexed citations

14.

Ciaffi, Laura, Matthias Cavassini, Daniel Genné, et al.. (2015). Switch to etravirine for HIV‐positive patients receiving statin treatment: a prospective study. European Journal of Clinical Investigation. 45(7). 720–730. 5 indexed citations

15.

Ciaffi, Laura, Sinata Koulla‐Shiro, Adrien Sawadogo, et al.. (2015). Efficacy and safety of three second-line antiretroviral regimens in HIV-infected patients in Africa. AIDS. 29(12). 1473–1481. 30 indexed citations

16.

Laurent, Christian, Charles Kouanfack, Anke Bourgeois, et al.. (2010). Hepatotoxicity and effectiveness of a Nevirapine-based antiretroviral therapy in HIV-infected patients with or without viral hepatitis B or C infection in Cameroon. BMC Public Health. 10(1). 105–105. 32 indexed citations

17.

Laurent, Christian, Anke Bourgeois, Eitel Mpoudi‐Ngolé, et al.. (2009). High rates of active hepatitis B and C co‐infections in HIV‐1 infected Cameroonian adults initiating antiretroviral therapy. HIV Medicine. 11(1). 85–89. 32 indexed citations

18.

Laurent, Christian, Anke Bourgeois, Eitel Mpoudi‐Ngolé, et al.. (2008). Tolerability and Effectiveness of First-Line Regimens Combining Nevirapine and Lamivudine Plus Zidovudine or Stavudine in Cameroon. AIDS Research and Human Retroviruses. 24(3). 393–400. 33 indexed citations

19.

Bourgeois, Anke, Christian Laurent, Rose Mougnutou, et al.. (2005). Field Assessment of Generic Antiretroviral Drugs: A Prospective Cohort Study in Cameroon. Antiviral Therapy. 10(2). 335–341. 44 indexed citations

20.

Davies, Stephen, et al.. (2003). Sexually Transmitted Infections Among Female Sex Workers in Kupang, Indonesia:. Sexually Transmitted Diseases. 30(9). 671–679. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact